Targeted muscle reinnervation: A narrative review of a novel tool for the management of neuropathic pathology in major lower extremity amputations

John Phair, Krystina Choinski, Dani C. Inglesby, Shawn Diamond, Steven M. Sultan

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The purpose of this narrative review is to provide the vascular surgery community with updated recommendations and information regarding the use of Targeted Muscle Reinnervation (TMR) for both the prevention and treatment of chronic pain and phantom limb pain occurring in patients after undergoing lower extremity amputation for peripheral artery disease. Methods: Current available literature discussing TMR is reviewed and included in the article in order to provide a succinct overview on the indications, clinical applications, and surgical technique for TMR. Additionally, early studies showing favorable long-term results after TMR are discussed. Patient consent for publication was obtained for this investigation. Results: TMR has been demonstrated to be an effective means of both treating and preventing neuroma-related symptoms including chronic pain and phantom limb pain. It has been proven to be technically feasible, and can help patients to have improved utilization of prostheses for ambulation, which can conceivably lead to a reduction in mortality. Conclusions: TMR is an important tool to consider for any patient undergoing lower extremity amputation for a vascular-related indication. A vascular-plastic surgeon dual team approach is an effective means to prevent and reduce neuromas and associated chronic pain in this patient population.

Original languageEnglish
Pages (from-to)154-161
Number of pages8
JournalVascular
Volume32
Issue number1
DOIs
StatePublished - Feb 2024

Keywords

  • Lower Extremity Amputation
  • Neuroma
  • Peripheral Artery Disease
  • Phantom Limb Pain
  • Targeted Muscle Reinnervation

Fingerprint

Dive into the research topics of 'Targeted muscle reinnervation: A narrative review of a novel tool for the management of neuropathic pathology in major lower extremity amputations'. Together they form a unique fingerprint.

Cite this